Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy (vol 23, 136, 2023)
Yükleniyor...
Tarih
2023
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
BMC
Erişim Hakkı
Attribution 4.0 International
info:eu-repo/semantics/openAccess
info:eu-repo/semantics/openAccess
Özet
Following publication of the original article [1], the authors reported an error in the author name of Enes Erul.
Açıklama
Anahtar Kelimeler
CDK 4/6 Inhibitor Therapy, Breast Cancer, Disease Progression
Kaynak
BMC Cancer
WoS Q Değeri
Q2
Scopus Q Değeri
Q2
Cilt
23
Sayı
1
Künye
Karacin, C., Öksüzoğlu, B., Demirci, A., Keskinkılıç, M., Köse Baytemur, N., Yılmaz, F. ... Hacıbekiroğlu, İ. (2023). Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy (vol 23, 136, 2023). BMC Cancer, 23(1). https://dx.doi.org/10.1186/s12885-023-10662-3
